416 related articles for article (PubMed ID: 33433883)
1. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
Asa SL; Mete O; Ezzat S
Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
[TBL] [Abstract][Full Text] [Related]
2. Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL; Larsen AG; Dunn IF
Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
[TBL] [Abstract][Full Text] [Related]
4. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract][Full Text] [Related]
5. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
Shen AJJ; King J; Scott H; Colman P; Yates CJ
Expert Rev Endocrinol Metab; 2019 Nov; 14(6):399-418. PubMed ID: 31793361
[No Abstract] [Full Text] [Related]
6. Overview of the 2022 WHO Classification of Pituitary Tumors.
Asa SL; Mete O; Perry A; Osamura RY
Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
[TBL] [Abstract][Full Text] [Related]
7. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
8. Pangenomic Classification of Pituitary Neuroendocrine Tumors.
Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G
Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Epigenetic Causes of Pituitary Adenomas.
Chang M; Yang C; Bao X; Wang R
Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
[TBL] [Abstract][Full Text] [Related]
11. Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
Spada A; Mantovani G; Lania AG; Treppiedi D; Mangili F; Catalano R; Carosi G; Sala E; Peverelli E
Neuroendocrinology; 2022; 112(1):15-33. PubMed ID: 33524974
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumours: molecular and genetic aspects.
De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
[TBL] [Abstract][Full Text] [Related]
14. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
[TBL] [Abstract][Full Text] [Related]
16. [Histological Classification and Diagnosis of Sellar/Parasellar Tumors].
Nishioka H
No Shinkei Geka; 2023 Sep; 51(5):789-798. PubMed ID: 37743330
[TBL] [Abstract][Full Text] [Related]
17. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
18. UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS.
Lim CT; Korbonits M
Endocr Pract; 2018 May; 24(5):473-488. PubMed ID: 29498920
[TBL] [Abstract][Full Text] [Related]
19. The Expression of Cell Cycle-Related Genes in
Mossakowska BJ; Rusetska N; Konopinski R; Kober P; Maksymowicz M; Pekul M; Zieliński G; Styk A; Kunicki J; Bujko M
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428684
[TBL] [Abstract][Full Text] [Related]
20. Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation - High-Grade PitNET or PitNEC?
Saeger W; Mawrin C; Meinhardt M; Wefers AK; Jacobsen F
Endocr Pathol; 2022 Jun; 33(2):257-262. PubMed ID: 34669159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
